283 related articles for article (PubMed ID: 29119120)
1. Computer-Aided Design of an Epitope-Based Vaccine against Epstein-Barr Virus.
Alonso-Padilla J; Lafuente EM; Reche PA
J Immunol Res; 2017; 2017():9363750. PubMed ID: 29119120
[TBL] [Abstract][Full Text] [Related]
2. Immunoinformatic and systems biology approaches to predict and validate peptide vaccines against Epstein-Barr virus (EBV).
Ali A; Khan A; Kaushik AC; Wang Y; Ali SS; Junaid M; Saleem S; Cho WCS; Mao X; Wei DQ
Sci Rep; 2019 Jan; 9(1):720. PubMed ID: 30679646
[TBL] [Abstract][Full Text] [Related]
3. Immunoinformatics Approach to Design Novel Subunit Vaccine against the Epstein-Barr Virus.
Moin AT; Patil RB; Tabassum T; Araf Y; Ullah MA; Snigdha HJ; Alam T; Alvey SA; Rudra B; Mina SA; Akter Y; Zhai J; Zheng C
Microbiol Spectr; 2022 Oct; 10(5):e0115122. PubMed ID: 36094198
[TBL] [Abstract][Full Text] [Related]
4. Epstein Barr Virus: Development of Vaccines and Immune Cell Therapy for EBV-Associated Diseases.
Cui X; Snapper CM
Front Immunol; 2021; 12():734471. PubMed ID: 34691042
[TBL] [Abstract][Full Text] [Related]
5. In silico identification of potential epitopes present in human adenovirus proteins for vaccine design and of putative drugs for treatment against viral infection.
Hossain R; Yasmin T; Hosen MI; Nabi AHMN
J Immunol Methods; 2018 Apr; 455():55-70. PubMed ID: 29371093
[TBL] [Abstract][Full Text] [Related]
6. mRNA-Based Vaccine Designing against Epstein-Barr Virus to Induce an Immune Response Using Immunoinformatic and Molecular Modelling Approaches.
Althurwi HN; Alharthy KM; Albaqami FF; Altharawi A; Javed MR; Muhseen ZT; Tahir Ul Qamar M
Int J Environ Res Public Health; 2022 Oct; 19(20):. PubMed ID: 36293632
[TBL] [Abstract][Full Text] [Related]
7. Contriving multiepitope subunit vaccine by exploiting structural and nonstructural viral proteins to prevent Epstein-Barr virus-associated malignancy.
Ojha R; Nandani R; Prajapati VK
J Cell Physiol; 2019 May; 234(5):6437-6448. PubMed ID: 30362500
[TBL] [Abstract][Full Text] [Related]
8. Expression and immunogenic characterization of recombinant gp350 for developing a subunit vaccine against Epstein-Barr virus.
Wang M; Jiang S; Han Z; Zhao B; Wang L; Zhou Z; Wang Y
Appl Microbiol Biotechnol; 2016 Feb; 100(3):1221-1230. PubMed ID: 26433969
[TBL] [Abstract][Full Text] [Related]
9. Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.
Tan LC; Mowat AG; Fazou C; Rostron T; Roskell H; Dunbar PR; Tournay C; Romagné F; Peyrat MA; Houssaint E; Bonneville M; Rickinson AB; McMichael AJ; Callan MF
Arthritis Res; 2000; 2(2):154-64. PubMed ID: 11062606
[TBL] [Abstract][Full Text] [Related]
10. Excavating chikungunya genome to design B and T cell multi-epitope subunit vaccine using comprehensive immunoinformatics approach to control chikungunya infection.
Narula A; Pandey RK; Khatoon N; Mishra A; Prajapati VK
Infect Genet Evol; 2018 Jul; 61():4-15. PubMed ID: 29535024
[TBL] [Abstract][Full Text] [Related]
11. B and T Cell Epitope-Based Peptides Predicted from Evolutionarily Conserved and Whole Protein Sequences of Ebola Virus as Vaccine Targets.
Yasmin T; Nabi AH
Scand J Immunol; 2016 May; 83(5):321-37. PubMed ID: 26939891
[TBL] [Abstract][Full Text] [Related]
12. A novel vaccine candidate based on chimeric virus-like particle displaying multiple conserved epitope peptides induced neutralizing antibodies against EBV infection.
Zhang X; Zhao B; Ding M; Song S; Kang Y; Yu Y; Xu M; Xiang T; Gao L; Feng Q; Zhao Q; Zeng MS; Krummenacher C; Zeng YX
Theranostics; 2020; 10(13):5704-5718. PubMed ID: 32483413
[No Abstract] [Full Text] [Related]
13. In silico T-cell and B-cell Epitope Based Vaccine Design Against Alphavirus Strain of Chikungunya.
Jadoon MH; Rehman Z; Khan A; Rizwan M; Khan S; Mehmood A; Munir A
Infect Disord Drug Targets; 2020; 20(4):523-530. PubMed ID: 31109281
[TBL] [Abstract][Full Text] [Related]
14. A bioinformatics tool for epitope-based vaccine design that accounts for human ethnic diversity: application to emerging infectious diseases.
Oyarzun P; Ellis JJ; Gonzalez-Galarza FF; Jones AR; Middleton D; Boden M; Kobe B
Vaccine; 2015 Mar; 33(10):1267-73. PubMed ID: 25629524
[TBL] [Abstract][Full Text] [Related]
15. Early T Cell Recognition of B Cells following Epstein-Barr Virus Infection: Identifying Potential Targets for Prophylactic Vaccination.
Brooks JM; Long HM; Tierney RJ; Shannon-Lowe C; Leese AM; Fitzpatrick M; Taylor GS; Rickinson AB
PLoS Pathog; 2016 Apr; 12(4):e1005549. PubMed ID: 27096949
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of a multiepitope plasmid DNA encoding T and B lymphocyte epitopes from latent membrane protein 2 (LMP2) of Epstein-Barr virus as a vaccine in mice.
Li W; Chen Q; Lin Q; Lv Y; Feng J; Liu J; Xu W; Chen S; Zhu X; Zhang L
Protein Pept Lett; 2013 Oct; 20(10):1136-43. PubMed ID: 23688153
[TBL] [Abstract][Full Text] [Related]
17. Immunization with Components of the Viral Fusion Apparatus Elicits Antibodies That Neutralize Epstein-Barr Virus in B Cells and Epithelial Cells.
Bu W; Joyce MG; Nguyen H; Banh DV; Aguilar F; Tariq Z; Yap ML; Tsujimura Y; Gillespie RA; Tsybovsky Y; Andrews SF; Narpala SR; McDermott AB; Rossmann MG; Yasutomi Y; Nabel GJ; Kanekiyo M; Cohen JI
Immunity; 2019 May; 50(5):1305-1316.e6. PubMed ID: 30979688
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus vaccine: a cytotoxic T-cell-based approach.
Bharadwaj M; Moss DJ
Expert Rev Vaccines; 2002 Dec; 1(4):467-76. PubMed ID: 12901585
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus strain heterogeneity impairs human T-cell immunity.
Cirac A; Stützle S; Dieckmeyer M; Adhikary D; Moosmann A; Körber N; Bauer T; Witter K; Delecluse HJ; Behrends U; Mautner J
Cancer Immunol Immunother; 2018 Apr; 67(4):663-674. PubMed ID: 29374782
[TBL] [Abstract][Full Text] [Related]
20. Peptides designed to spatially depict the Epstein-Barr virus major virion glycoprotein gp350 neutralization epitope elicit antibodies that block virus-neutralizing antibody 72A1 interaction with the native gp350 molecule.
Tanner JE; Coinçon M; Leblond V; Hu J; Fang JM; Sygusch J; Alfieri C
J Virol; 2015 May; 89(9):4932-41. PubMed ID: 25694592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]